focus -WSS

focus

author：fashion 2025-09-29 19:59:20 - browse：865

Christoph Lengauer stands for a portrait. -- biotech coverage from STAT — Christoph Lengauer, co-founder and CSO of Curie.Bio Vanessa Leroy for STAT

Curie.Bio, the new biotech investment firm and incubator launched earlier this year by a group of industry veterans including Alexis Borisy and Zach Weinberg, has graduated its first startup.

The startup, Forward Therapeutics, is coming out of the incubator with three drug candidates for chronic inflammatory disorders. It also just closed its first major financing round: a $50 million Series A round led by BVF Partners, with participation from RA Capital Management and OrbiMed. That money should be enough for Forward to begin clinical trials — a rare feat in the biotech world, where companies often need to raise multiple private financing rounds in order to be ready for human tests.

“Usually, with Series A money, you get a development candidate, and use Series B to take molecules to the clinic,” Forward CEO Toufike Kanouni told STAT. But with the Curie team’s help, and the $8 million in seed financing it provided, Forward was able to move much faster.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Teach medical students about patients with intellectual disabilities

knowledge

WSS

Radiology is caught between AI's potential and concern for patients

Supreme Court wrestles with OxyContin maker's bankruptcy deal

What PEPFAR has meant on the ground in Ukraine

Novo Nordisk testing Wegovy against alcohol

Oak Street deal isn't the answer to health care's woes

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

knowledge

focus

Wikipedia

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

CMS should re

Sports medicine is finally prioritizing gender equality

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

Trump demands the U.S. pay no more for drugs than other countries … again

Patients' immediate access to test results puts radiologists in a bind

DIEP, the 'gold standard' of breast reconstruction, is under threat

Pharma patents targeted by Biden in move to slash drug prices

Peter Hotez and the public health issue of online harassment

Leukemia patients are helped by Syndax's new type of therapy

Wikipedia

What a koala virus tells us about the human genome

After sickle

Why sickle cell disease is getting the first CRISPR treatment

Cherokee Nation medical school graduates its first class

Leukemia patients are helped by Syndax's new type of therapy

STAT reporters are Pulitzer Prize finalists for investigative reporting

hotspot

focus

knowledge

hotspot